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http://www.journal-inflammation.com/content/11/1/4RESEARCH Open AccessSalivary histatin 3 inhibits heat shock cognate
protein 70-mediated inflammatory cytokine
production through toll-like receptors in human
gingival fibroblasts
Yasuhiro Imamura1* and Pao-Li Wang2Abstract
Background: Salivary histatins are bioactive peptides related to the innate immune system associated with
antimicrobial activities. However, very little is known about the physiological and biological functions of histatins
against host cells or their role in oral cell inflammation. Histatin 3 binds to heat shock cognate protein 70 (HSC70,
a constitutively expressed heat shock protein (HSP)). It is unclear whether HSC70 is involved in the inflammatory
response in oral cells. Injured oral cells release some intracellular proteins including HSC70. It is possible that
released HSC70 induces toll-like receptor (TLR) activation, just as extracellular HSP70 (a stress inducible HSP) does,
and that histatin 3 affects this process. Therefore, we tested the hypothesis that HSC70 activates TLR signaling and
histatin 3 inhibits this activation and inflammatory cytokine production.
Methods: A nuclear factor (NF)-κB-dependent luciferase reporter plasmid was transfected into HEK293 cells stably
expressing TLR2 with coreceptor CD14 (293-TLR2/CD14 cells) or stably expressing TLR4 with CD14 and the
accessory molecule MD2 (293-TLR4/MD2-CD14 cells). The cells were stimulated with HSC70 in the presence or
absence of histatin 3, and examined using luciferase assays. We also stimulated human gingival fibroblasts (HGFs)
with HSC70 with or without histatin 3. Then, we analyzed the levels of inflammatory cytokines (interleukin (IL)-6
and IL-8) in the culture media. Cell proteins were analyzed using enzyme-linked immunosorbent assay and Western
blotting with antibodies of mitogen-activated protein kinases and NF-κB inhibitor IκB-α, respectively. Histatin
3-bound form of HSC70 was analyzed using limited V8 protease proteolysis.
Results: HSC70 induced NF-κB activation in a dose-dependent manner in 293-TLR2/CD14 and 293-TLR4/MD2-CD14
cells, and histatin 3 inhibited this process and when histatin 3 binding to HSC70 was precluded by 15-deoxyspergualin,
which augmented NF-κB-triggered activation. In HGFs, histatin 3 also inhibited HSC70-induced inflammatory cytokine
production, extracellular signal-regulated protein kinase phosphorylation, and degradation of IκB-α. Moreover, HSC70 in
the presence of histatin 3 was relatively resistant to digestion by V8 protease compared with HSC70 in the presence of
control peptide.
Conclusions: Histatin 3 may be an inhibitor of HSC70-triggered activation of TLR signaling and inflammatory cytokine
production and may be involved in inflammation processes noted in oral cells.
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Histatins constitutively secreted by the salivary glands
are associated with innate immunity processes in the
oral cavity. These peptides have antimicrobial properties
and protect oral tissues from pathogens [1]. The histatin
family comprises 12 histidine-rich cationic peptides found
in healthy adults at concentrations of 50–425 μg/ml, cor-
responding to approximately 10% of total protein in saliva
[2-4]. Histatins 1 and 3 are full-length peptides of 38 and
32 amino acid residues, respectively; other characterized
members of the histatin family are proteolytic products
formed during secretion [2,5]. Histatins 3 and 5 are the
heat shock protein (HSP)-binding proteins that are most
abundant in saliva and are active against Candida albicans
and Porphyromonas gingivalis (the pathogen of periodon-
titis) [6-10]. In addition, histatins 3 and 5 are also involved
in proliferation of human gingival fibroblasts (HGFs) and
rabbit costal chondrocytes, respectively [7,11].
HSPs are induced by a wide variety of stresses in pro-
karyotic and eukaryotic cells, including environmental,
pathological, and physiological stimuli [12]. HSPs func-
tion as ATPase activity-dependent molecular chaperones
that assist in the correct folding of proteins, the assem-
bly of various protein complexes, transport of proteins
across membranes into organelles, and the degradation
of proteins by the lysosome [13-15]. Heat shock cognate
protein 70 (HSC70), an HSP family member, is a cyto-
solic protein that is abundantly, constitutively, and ubi-
quitously expressed in most cells [16]. HSC70 consists
of an ATPase domain (amino acid residues 1–384), a
substrate (peptides, including histatin 3)-binding domain
(amino acid residues 385–543), and a lid domain (amino
acid residues 544–646) [7,17]. Three-dimensional struc-
ture of the ATPase domain has been determined by
X-ray crystallography; the structure of this domain is
similar to that of hexokinase and actin [18,19].
Toll-like receptors (TLRs) have been identified as hu-
man homologs of Drosophila Toll receptors, which are
involved in innate immunity [20,21]. TLRs recognize
their respective pathogen-associated molecular patterns
(PAMPs) and damage-associated molecular patterns
(DAMPs, such as intracellular proteins released from
damaged and necrotic cells) [22]. TLR2, a TLR family
member, recognizes peptidoglycan (PGN, a major cell-wall
component of gram-positive bacteria), lipopolysaccharide
(LPS) from P. gingivalis, and HSP70 (a stress-induced
HSP) [23-25]. TLR4 is another TLR family member, which
recognizes LPS from the outer membranes of gram-
negative bacteria and HSPs such as HSP70, HSP60, and
Gp96 [25-28]. TLR2 and TLR4 require their interacting
proteins for the recognition of some PAMPs and DAMPs.
TLR2 can induce nuclear factor (NF)-κB activation in re-
sponse to HSP70 stimulation, but only in the presence of
CD14, a glycosylphosphatidylinositol-anchored protein[25]. In order for TLR4 to function satisfactorily as a re-
ceptor for LPS, both MD2 and CD14 must be coexpressed
[29,30]. Once TLR2 and TLR4 recognize their respective
ligands, the specific response initiated by these TLRs
depends on the recruitment of adaptor proteins (e.g., mye-
loid differentiation primary response protein 88 or Toll-
interleukin (IL)-1 receptor domain-containing adaptor
protein). These adaptor proteins transmit signals that re-
sult in the activation of mitogen-activated protein kinases
(MAPKs) and NF-κB and the induction of inflammatory
cytokines [31].
It is not known whether HSC70 is involved in the in-
flammatory responses in oral cells, such as the produc-
tion of inflammatory cytokines. It has been proposed
that oral diseases accompanying damage or oral injuries
cause the release of some intracellular proteins, includ-
ing HSC70. If HSC70, like HSP70, functions as DAMPs,
HSC70 could be a putative inducible factor in the
inflammatory response in oral cells through TLRs.
HGFs, which constitute the major cellular population of
gingival tissue, express TLR2, TLR4, MD2, and CD14
[32-34]. In addition, histatin 3 in saliva may associate with
the released HSC70. Therefore, we can infer that histatin
3 inhibits TLR-mediated HSC70 function, reducing the
production of inflammatory cytokine in oral cells.
In this study, we identified HSC70 as a putative ligand
of TLR2 and TLR4. We observed the inhibitory effect of
histatin 3 on inflammatory cytokine production in HGFs
and on NF-κB activation in HEK293 cells expressing
TLR2 or TLR4 as a result of HSC70 stimulation. These
findings represent our current knowledge of physio-
logical functions of salivary proteins in oral cavity.
Methods
Cell cultures
The stable cell lines, 293-TLR4/MD2-CD14 (InvivoGen)
and 293-TLR2/CD14 (InvivoGen) and HGFs were cultured
in Dulbecco’s modified Eagle medium (DMEM; Sigma-
Aldrich) with 10% fetal bovine serum (FBS), 100 units/ml
of penicillin G, and 100 μg/ml of streptomycin at 37°C in
5% CO2 and 95% air in a humidified incubator. HGFs were
collected from volunteers after obtaining appropriate in-
formed consent. The Ethics Committee of Matsumoto
Dental University approved the study protocol.
Reagents
The following materials and antibodies were purchased:
LPS from Escherichia coli 0128:B12 (Sigma-Aldrich);
LPS from P. gingivalis (InvivoGen); recombinant human
HSP70 (Stressgen; endotoxin activity, <0.05 endotoxin
units (EU)/μg); recombinant bovine HSC70 (Stressgen;
<0.05 EU/μg); recombinant bovine HSC70 ATPase
fragment (Enzo Life Sciences; 0.1 EU/μg); V8 protease
(Roche); 15-deoxyspergualin (DSG) (Spanidin® Inj.; Nippon
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TLR2 (TL2.1) antibodies (Hycult Biotechnology); mouse
monoclonal anti-CD14 (MY4) antibody (Beckman Coulter);
rabbit polyclonal anti-p44/42, anti-p38, anti-phosphorylated
p38, anti-phosphorylated IκB-α, mouse monoclonal anti-
phosphorylated p44/42 antibodies (Cell Signaling); mouse
monoclonal anti-JUN-N-terminal protein kinase (JNK)
(D-2), anti-phosphorylated JNK (G-7), anti-IκB-α (H-4)
antibodies (Santa Cruz Biotechnology); and mouse mono-
clonal anti-β-actin antibody (Abcam). Endotoxin levels of
all materials used were determined using a ToxinSensor
chromogenic LAL endotoxin assay kit (GenScript), and the
resultant level was low (~0.1 EU/μg). The LPS, bovine
serum albumin (BSA), HSP70, HSC70, and the HSC70
ATPase fragment were heated at 95°C for 20 min.
Peptides
Human histatins 3, 4, and 5 and P3a peptide (Biosyn-
thesis Inc.) were chemically synthesized [7]. The control0
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Figure 1 The effect of HSC70 on NF-κB-dependent activation through
by HSC70 through TLR4. 293-TLR4/MD2-CD14 cells were transfected with a
after transfection, cells were stimulated with heated and unheated E. coli LPS,
cells were analyzed by luciferase assays. The values are shown as fold inductio
(none). (B) Luciferase assays for NF-κB-dependent activation by the ATPase fra
in (A), except that the cells were stimulated with the heated or unheated HSC
by HSC70 through TLR2. The procedures were as in (A), except that 293-TLR2
NF-κB-dependent activation by the HSC70 ATPase fragment in 293-TLR2/CD1
and range of duplicate samples.peptide, (Pro-Pro-Gly)10 · 9H2O, was purchased from
Peptide Institute Inc.
Transfection and luciferase assays
pIgκB-Luc (1 μg) and pRSV-β-gal (0.1 μg), as the standard
plasmid, were mixed with TransIT-LT1 transfection re-
agents (Mirus) [35]. The mixtures were transfected into
3 × 105 cells. One day after transfection, the cells were
stimulated using LPSs from E. coli (20 ng/ml) or P. gingi-
valis (100 ng/ml). For 293-TLR4/MD2-CD14 cells, the in-
cubation mixtures also contained 1.4 or 14 nM BSA,
HSP70, or HSC70 or 14 nM heated HSP70, heated
HSC70, or the HSC70 ATPase fragment (heated or un-
heated). For 293-TLR2/CD14 cells, the incubation mix-
tures contained 2.8 or 28 nM BSA, HSP70, or HSC70 or
28 nM heated HSP70, heated HSC70, or the HSC70
ATPase fragment (heated or unheated). Cells were har-
vested and lysed 6 h after stimulation. Luciferase and
β-galactosidase activities in the lysates were measured asB
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TLR2 and TLR4. (A) Luciferase assays for NF-κB-dependent activation
n NF-κB-dependent luciferase reporter plasmid (pIgκB-Luc). One day
BSA, HSP70, or HSC70 for 6 h. Cell lysates prepared from the stimulated
n of the standardized luciferase activity over the unstimulated control
gment of HSC70 in 293-TLR4/MD2-CD14 cells. The procedures were as
70 ATPase fragment. (C) Luciferase assays for NF-κB-dependent activation
/CD14 cells and P. gingivalis LPS were used. (D) Luciferase assays for
4 cells. The procedures were as in (A and B). Bars represent the means
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compared after normalization against the standard (β-ga-
lactosidase activity). For the peptide experiments, the
stimulant (20 ng/ml, E. coli LPS or 14 nM, HSP70 or
HSC70 for 293-TLR4/MD2-CD14 cells; 100 ng/ml, P. gin-
givalis LPS or 28 nM, HSP70 or HSC70 for 293-TLR2/
CD14 cells) and respective peptides (3 or 30 μM; stimula-
tion with peptide alone, 30 μM) were mixed. For the DSG
experiments, HSC70 (14 nM for 293-TLR4/MD2-CD14
cells and 28 nM for 293-TLR2/CD14 cells) and the pep-
tides (30 μM) were mixed with DSG (10 μg/ml). All the
above mixtures were placed on ice for 30 min before being
added to transfected cells. The cells were then cultured for
6 h. Figures show representative examples of 3 identical
experiments with essentially identical results.
Western blotting
HGFs (1.2 × 105) were cultured in DMEM containing 0.1%-
0.5% FBS for 24 h. Cells were stimulated using 10 ng/ml LPSA
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Figure 2 The effect of histatin 3 on NF-κB-dependent activation by H
dependent activation by HSC70 through TLR2 and TLR4 in the presence of
transfected with pIgκB-Luc, and were stimulated with mixtures of the indic
from the stimulated cells were analyzed by luciferase assays. The values are
the unstimulated control (none). **, P < 0.01; ***, P < 0.001 versus stimulatio
assays for NF-κB-dependent activation by HSC70 through TLR2 and TLR4 in
as in (A and B), except that stimulations were with mixtures of HSC70 and
samples. *, P < 0.05; **, P < 0.01 versus stimulation with HSC70 alone. †, P <or 0.5 μg/ml HSC70 for the indicated time periods. For
peptide experiments, 1.5 μg/ml HSC70 and 0.05 or 0.5 μM
peptides (stimulation of peptide alone, 0.5 μM) were mixed
and placed on ice for 15 min. The mixtures were added
to low serum-cultured HGFs. After 30 min, the cells were
lysed with radioimmunoprecipitation assay (RIPA) buffer
(50 mM, Tris–HCl (pH 7.5); 5 mM, EDTA; 150 mM,
NaCl; 1% NP-40; 0.1% sodium dodecyl sulfate (SDS); 0.5% so-
dium deoxycholate; 1 mM, phenylmethylsulfonyl fluoride;
10 μg/ml, leupeptin; 10 μg/ml, aprotinin; 5 mM, Na3VO4;
10 mM, NaF). Western blotting analyses were performed
as previously described [35,36]. Figures of Western blot-
ting are representative of 3 independent experiments with
similar results. Relative band intensity was measured using
the ImageJ software (http://imagej.nih.gov/ij/).
Enzyme-linked immunosorbent assays (ELISAs)
HGFs (1 × 104) were cultured with HSC70 (7 or 70 nM),
heated HSC70 (70 nM), or the unheated or heatedHSC70
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SC70 through TLR2 and TLR4. (A, B) Luciferase assays for NF-κB-
histatin 3. 293-TLR4/MD2-CD14 (A) and 293-TLR2/CD14 (B) cells were
ated peptides and LPS, HSP70, or HSC70 for 6 h. Cell lysates prepared
shown as fold induction of the standardized luciferase activity over
n with HSC70 alone. cont. pep., control peptide. (C, D) Luciferase
the presence of histatin family members. The procedures were same
histatins 3, 4, or 5. Bars represent the means and range of duplicate
0.05; ††, P < 0.01.
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http://www.journal-inflammation.com/content/11/1/4HSC70 ATPase fragment (70 nM) for 24 h. For antibody
experiments, HGFs were cultured with 10 μg/ml anti-
TLR4, anti-TLR2, or anti-CD14 antibodies for 1 h. LPSs
(from E. coli, 10 ng/ml; from P. gingivalis, 5 ng/ml) and
HSC70 (70 nM) were then added to the cells, and the
cells were cultured for 24 h. For peptide experiments,
HSC70 (70 nM) and peptides (0.15 μM and 1.5 μM)
were mixed and placed on ice for 15 min. The mixtures
were added to the cells and cultured for 24 h. The cul-
ture media from all the above experiments were col-
lected, and levels of IL-6 and IL-8 were measured using
CytoSet kits (Biosource). Figures show representative ex-
amples of three identical experiments with essentially
identical results.Limited proteolysis with V8 protease
HSC70 (2.1 μM) and peptides (10.5 μM) in a buffer
(50 mM, Tris-HCl (pH 8.0); 0.5 mM, DTT; 150 mM,
NaCl) were placed on ice for 10 min. After the addition
of V8 protease (75 or 750 ng), the mixtures were incu-
bated at 30°C for 1.5 h. The reactions were terminated
by the addition of 0.5 volume of 2× SDS sample buffer
(140 mM, Tris–HCl (pH 7.0); 6% SDS; 10% mercap-
toethanol; 22.4% glycerol; 0.02% bromphenol blue; and
2 mM, phenylmethylsulfonyl fluoride). The samples were
heated at 100°C for 5 min, and the proteolytic fragments
were resolved using 12% SDS-polyacrylamide gel elec-
trophoresis (PAGE) gels, followed by staining with
Coomassie Brilliant Blue. Figure is representative of 3 in-
dependent experiments with similar results.A
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Figure 3 The effect of DSG on NF-κB-dependent activation by HSC70
after transfection with pIgκB-Luc in 293-TLR4/MD2-CD14 (A) and 293-TLR2/
histatin 3 in the presence or absence of DSG for 6 h. Cell lysates prepared
are shown as fold induction of the standardized luciferase activity over the
range of duplicate samples. *, P < 0.05; **, P < 0.01, ***, P < 0.001 versus stimStatistical analysis
All quantitative data were statistically analyzed using
either one-way analysis of variance (ANOVA) or two-way
ANOVA using the StatMate software (ATMS). Differences
were considered statistically significant at P < 0.05.Results
NF-κB activation by stimulation with exogenous HSC70
through TLR2 and TLR4
HSP70 stimulates inflammatory cytokine production
(e.g., IL-6 and tumor necrosis factor-α) in monocytes
and dendritic cells through TLR2 and TLR4 [25,37].
However, the activation of inflammatory cytokine pro-
duction by HSC70, even though it belongs to the same
HSP family as HSP70, is poorly understood. Therefore,
we investigated whether cytokine production by HSC70
is mediated by TLRs and their interacting proteins such
as HGFs, particularly in oral cells. Because HGFs express
TLR2 and TLR4, it is necessary to perform systematic
experiments investigating the dependence of HSC70
stimulation on TLR2 or TLR4. It has been reported that
HSP70 stimulation induces NF-κB activation in 293T
cells transiently expressing TLR4 and MD2, but not in
the cells expressing TLR4 alone [38]. In contrast, till
now there has been no evidence that HSC70 activates
NF-κB in HEK293 cells expressing TLRs. Therefore, we
examined NF-κB activation in the stable cell line 293-
TLR4 (HEK293 cells constitutively expressing TLR4)
transiently transfected with an MD2 expression vector
and an NF-κB-dependent luciferase reporter plasmid.293-TLR2/CD14
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from the stimulated cells were analyzed by luciferase assays. The values
unstimulated control (none, DSG (−)). Bars represent the means and
ulation with HSC70 alone. †††, P < 0.001.
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Figure 4 The effect of HSC70 on inflammatory cytokine
production in HGFs. (A, B) IL-6 and IL-8 production by HSC70
stimulation in HGFs. Unheated HSC70 (7 and 70 nM) and heated
HSC70 (70 nM) were added to HGFs (left). Unheated or heated
HSC70 ATPase fragment (70 nM each) were also added to HGFs
(right). The cells were cultured for 24 h. The amounts of IL-6 (A)
and IL-8 (B) in the culture media were measured by ELISAs. Bars
represent the means and range of duplicate samples. *, P < 0.05;
**, P < 0.01; ***, P < 0.001 versus unstimulated (none).
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dependent promoter activity through TLR4/MD2 signal-
ing pathway. Moreover, when CD14 and MD2 were both
expressed in 293-TLR4 cells, the promoter activation by
HSC70 was more effective than that in 293-TLR4 cells
transiently expressing MD2 alone (data not shown).
We then examined whether this activation was dose-
dependent. The stable cell line 293-TLR4/MD2-CD14
(HEK293 cells constitutively expressing TLR4, MD2, and
CD14) transfected with the NF-κB-dependent reporter
plasmid (293-TLR4/MD2-CD14/NF-κB) was stimulated
with HSC70, and luciferase assays were performed. As
shown in Figure 1A, both HSC70 and HSP70 (control)
induced promoter activation in a dose-dependent man-
ner, whereas BSA did not. Promoter activity levels with
heated HSC70 and HSP70 were similar to those in
unstimulated cells. When 293-TLR4/MD2-CD14/NF-κB
cells were stimulated with the heated or unheated
HSC70 ATPase fragments (HSC70 with deletions of the
substrate-binding and lid domains), the promoter activa-
tion was at a lower level (Figure 1B). These results sug-
gest that HSC70 as well as E. coli LPS induces NF-κB
activation through TLR4/MD2/CD14 system.
HSP70 also induces NF-κB activation in stable HEK293-
TLR2 cells transiently expressing CD14, but not in
HEK293-TLR2 without CD14 [25]. Therefore, we exam-
ined NF-κB activation by HSC70 in the stable cell line
293-TLR2/CD14 (HEK293 cells constitutively expressing
TLR2 and CD14) transfected with the NF-κB-dependent
reporter plasmid (293-TLR2/CD14/NF-κB). As shown in
Figure 1C, HSC70 as well as HSP70 (control), but not
BSA, induced the promoter activation through TLR2/
CD14 in a dose-dependent manner. Heated and unheated
P. gingivalis LPSs induced promoter activation, whereas
heated HSC70 and heated HSP70 reduced activation com-
pared with the respective unheated HSPs. When the cells
were stimulated with heated and unheated HSC70 ATPase
fragments, only low levels of the promoter activation were
observed (Figure 1D). These results suggest that both
HSC70 and P. gingivalis LPS induce NF-κB activation
through TLR2/CD14.
Inhibitory effects of histatin 3 on HSC70-induced NF-κB
activation through TLR2 and TLR4
We have previously reported that salivary protein hista-
tin 3 binds to HSC70, but not HSP70 [7]. Here, we ex-
amined the effects of histatin 3 on NF-κB activation
by HSC70 through TLR2 and TLR4. 293-TLR4/MD2-
CD14/NF-κB and 293-TLR2/CD14/NF-κB cells were
stimulated with mixtures of HSC70 and a control pep-
tide, P3a (a peptide derived from the clathrin light chain
that stimulates ATP hydrolysis through HSC70 [39]), or
histatin 3, and luciferase assays were performed. The re-
sults showed that NF-κB-dependent promoter activation,stimulated by HSC70 through TLR4/MD2/CD14 or
TLR2/CD14, was significantly suppressed by histatin 3
in a dose-dependent manner. Figure 2A shows results
for TLR4/MD2/CD14 (histatin 3, 3 μM (P < 0.001) and
30 μM (P < 0.001)), and Figure 2B for TLR2/CD14 (his-
tatin 3, 3 μM (P < 0.01) and 30 μM (P < 0.001)). How-
ever, histatin 3 did not affect promoter activation caused
by LPS (from E. coli or P. gingivalis) or HSP70, in either
cell type. Neither the control peptide nor P3a inhibited
the LPS-, HSP70-, or HSC70-induced activation. We
then tested whether other members of the histatin
family were capable of suppressing NF-κB-dependent ac-
tivation through TLR4/MD2/CD14 or TLR2/CD14. 293-
TLR4/MD2-CD14/NF-κB and 293-TLR2/CD14/NF-κB
cells were stimulated with mixtures of HSC70 and hista-
tins 3, 4, or 5, and luciferase assays were performed. As
shown in Figures 2C and 2D, HSC70-induced promoter
activation was significantly reduced in the presence of
histatin 3 compared with that in the presence of histatin
5 (P < 0.05 in both cell types). The suppressive effects of
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http://www.journal-inflammation.com/content/11/1/4histatin 4 on the HSC70-mediated promoter activation
were at low levels. These results suggest that histatin 3
bound to HSC70 inhibits HSC70-induced NF-κB activa-
tion both in TLR4/MD2/CD14 and TLR2/CD14 mode.
Effect of DSG on HSC70-induced NF-κB activation through
TLR2 and TLR4 in the presence of histatin 3
We investigated whether the specific interaction of
histatin 3 and HSC70 was necessary for inhibition of
HSC70-induced NF-κB activation. The NF-κB-driven
luciferase assays were performed on 293-TLR4/MD2-
CD14/NF-κB and 293-TLR2/CD14/NF-κB cells treated
with HSC70 along with or without histatin 3 in the pres-
ence or absence of DSG. DSG is a synthetic analog of
spergualin, a natural product from Bacillus laterosporus,
and has a peptidomimeric structure. It binds particularlyA
n
o
n
e
-
TL
R
4
Ig
G
-
TL
R
2
Ig
G
Ig
G
-
TL
R
4 
+ 
-
TL
R
2
E. coli 
LPS 
H
B
antibodies
( g/ml) 
10 10 1
P. gingivalis
LPS
- --
Ig
G
20 
-
TL
R
4 
+ 
-
TL
R
2Ig
G
20 
IL
-6
 (p
g/m
l)
0
200
400
600
800
n
o
n
e
-
TL
R
4
Ig
G
-
TL
R
2
Ig
G
Ig
G
-
TL
R
4 
+ 
-
TL
R
2
E. coli 
LPS 
antibodies
( g/ml) 
10 10 1
P. gingivalis
LPS
- --
Ig
G
20 
-
TL
R
4 
+ 
-
TL
R
2Ig
G
20 
IL
-8
 (p
g/m
l)
0
200
400
600
Figure 5 The effect of anti-TLR antibodies on HSC70-stimulated inflam
production with LPS or HSC70 in the presence of anti-TLR2 and anti-TLR4 ant
antibodies and were then stimulated with LPSs or HSC70 for 24 h, and ELISAs
HSC70-stimulated IL-6 and (D) IL-8 production in the presence of anti-CD14 a
IgG served as the antibody control. Bars represent the means and range of du
HSC70 alone.well to HSC70 and is considered to preclude peptide
binding to HSC70 [40,41]. The results demonstrated that
in the presence of histatin 3 and DSG HSC70-stimulated
NF-κB-dependent promoter activity was significantly
higher than with histatin 3 alone in both 293-TLR4/
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(Figure 3B, P < 0.001) cells. These results suggest that
the specific binding of histatin 3 to HSC70 is important
for inhibition of HSC70-mediated activation of TLR2
and TLR4 signaling activation.
Production of inflammatory cytokines by HSC70
stimulation in HGFs
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Figure 6 The effect of histatin 3 on HSC70-stimulated inflam-
matory cytokine production in HGFs. (A) HSC70-stimulated IL-6
and (B) IL-8 production in the presence of histatin 3 in HGFs. HGFs
were stimulated with HSC70 in the presence of control peptide
(cont. pep.), P3a, or histatin 3 for 24 h, and the amounts of IL-6 and
IL-8 in the culture media were measured by ELISAs. Bars represent
the means and range of duplicate samples. ***, P < 0.001 versus
stimulation with HSC70 alone. (C) IL-6 and (D) IL-8 production in
HGFs after stimulation with HSC70 in the presence of histatin family
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http://www.journal-inflammation.com/content/11/1/4HGFs were stimulated with HSC70 for 24 h, and the
amounts of IL-6 and IL-8 in the culture media were
measured by ELISAs. As shown in Figures 4A and 4B,
unheated HSC70 significantly induced cytokine produc-
tion in HGFs in a dose-dependent manner, whereas
heated HSC70 did not induce cytokine production
(HSC70, 7 nM (P < 0.01) and 70 nM (P < 0.001) in
Figure 4A; 7 nM (P < 0.05) and 70 nM (P < 0.01) in
Figure 4B). When HGFs were stimulated with the un-
heated and heated HSC70 ATPase fragments, the levels
of IL-6 and IL-8 were similar to those in unstimulated
cells. These results suggest that HSC70 induces inflam-
matory cytokine production in HGFs.
Inhibitory effect of anti-TLR antibodies on inflammatory
cytokine production stimulated by HSC70 in HGFs
To examine whether inflammatory cytokine production
stimulated by HSC70 was dependent on TLR2 or TLR4
in HGFs, we performed experiments using anti-TLR2
and anti-TLR4 antibodies. As shown in Figure 5A, levels
of HSC70-stimulated IL-6 production in HGFs with
anti-TLR4, anti-TLR2, and both antibodies significantly
decreased (P < 0.001). LPS-stimulated IL-6 production
also significantly decreased in the presence of anti-TLR4
and both anti-TLR2 and anti-TLR4 antibodies (P < 0.001).
The patterns of HSC70- and LPS-stimulated IL-8 produc-
tion in the presence of the antibodies were similar to those
of IL-6 production under the same condition (Figure 5B).
Next, we examined the effect of anti-CD14 antibody on
HSC70- and LPS-stimulated inflammatory cytokine pro-
duction in HGFs. HSC70-stimulated IL-6 and IL-8 pro-
duction significantly decreased in the presence of this
antibody (P < 0.001) (Figures 5C and 5D). The antibody
also caused a decrease in cytokine production in LPS-
stimulated HGFs. The levels of IL-6 and IL-8 production
under HSC70 stimulation were approximately1.6-fold
higher than those by LPS stimulation. This behavior is
similar to the previously reported findings for HSP70
stimulation of cytokine production through a CD14-
dependent pathway [37]. These results suggest that
HSC70-stimulated inflammatory cytokine production in
HGFs is dependent on TLR2, TLR4, and CD14.
Inhibitory effect of histatin 3 on HSC70-stimulated
inflammatory cytokine production in HGFs
Histatin 3 was found to inhibit NF-κB activation
through TLR2 and TLR4 (Figure 2). We then exam-
ined the effect of histatin 3 on HSC70-stimulated in-
flammatory cytokine production in HGFs. HSC70 and
histatin 3 were added to HGFs, and the amounts of
IL-6 and IL-8 released into the culture media were
measured by ELISAs. As shown in Figures 6A
and 6B, HSC70-stimulated cytokine production sig-
nificantly decreased in the presence of histatin 3, in adose-dependent manner (histatin 3, 0.15 μM (P < 0.001)
and 1.5 μM (P < 0.001)). The control peptide and
P3a did not appreciably affect the cytokine produc-
tion. We then investigated whether other members
of the histatin family were capable of inhibiting
HSC70-stimulated cytokine production in HGFs.
Histatins 3, 4, and 5 were mixed with HSC70 and
used to stimulate HGFs, and the amounts of IL-6
and IL-8 in the culture media were measured. As
shown in Figures 6C and 6D, the inhibitory effect of
histatin 3 on the cytokine production was significantly
higher than that of histatin 5 (IL-6, P < 0.01; IL-8,
P < 0.001). These results suggest that histatin 3 is an in-
hibitory factor of HSC70-stimulated inflammatory cyto-
kine production in HGFs.
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http://www.journal-inflammation.com/content/11/1/4Effects of histatin 3 on HSC70-stimulated MAPK
phosphorylation and IκB-α degradation in HGFs
We next examined whether HSC70 stimulated MAPKs
(extracellular signal-regulated kinases (ERK (p42/44)),
JNK, and p38) phosphorylation and IκB-α degradation
in HGFs. HGFs were cultured with HSC70 for 10, 30,
and 60 min, and extracted proteins were analyzed
by Western blotting with anti-MAPK and anti-IκB-α
antibodies. As shown in Figures 7A and 7B, enhanced
phosphorylation of p42/44, JNK, p38, and IκB-α and
stimulated significant degradation of IκB-α by HSC70
were observed. LPSs also stimulated significantly both
the phosphorylation of MAPKs and IκB-α and the deg-
radation of IκB-α.A
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http://www.journal-inflammation.com/content/11/1/4in the presence of histatin 3. These results suggest that
histatin 3 inhibits HSC70-mediated MAPK phosphoryl-
ation and IκB-α degradation in HGFs.
Histatin 3 binding-induced protease-resistant
conformation of HSC70
Histatin 3 prevented HSC70-stimulated NF-κB activa-
tion through TLR2 and TLR4 (Figure 2) and inflamma-
tory cytokine production in HGFs (Figure 6). Therefore,
we assumed that histatin 3 binding to HSC70 had some
effect on the conformation of HSC70. To examine this
assumption, HSC70 was mixed with histatin 3, and the
mixture was analyzed by limited V8 protease proteolysis.
As shown in Figure 8, HSC70 with histatin 3 was rela-
tively more resistant to digestion by V8 protease with
HSC70 with the control peptide or P3a. Histatin 3 did
not inhibit the activity of V8 protease (data not shown).
These results suggest that histatin 3 may affect the con-
formation of HSC70 upon binding.
Discussion
It has been reported that extracellular HSP70 induces
inflammatory cytokine production through TLR2 and
TLR4 pathway in human monocytes [25]. However, it is
not known whether HSC70 activates TLR2 and TLR4
signaling in oral cells, and if so, whether intravital
(bioactive) factors that inhibit HSC70 function exist in
saliva. In this study, we found that HSC70, along with
MD2/CD14, stimulated TLR4 and that HSC70, along
with CD14, stimulated TLR2, resulting in the induction
of NF-κB-dependent activation. HSC70 also induced in-
flammatory cytokine production, MAPK phosphoryl-
ation, and IκB-α degradation in HGFs. Histatin 3- Hi
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Figure 8 Protease-resistant conformation in histatin 3-bound
HSC70. HSC70 was mixed with control peptide (cont. pep.), P3a, or
histatin 3, and the mixtures were analyzed by limited V8 protease
proteolysis. The ratios of V8 protease to HSC70 were 2:1 and 20:1
(w/w). The mixtures were incubated at 30°C for 1.5 h, and the
proteolytic fragments were separated on 12% SDS-PAGE gels and
stained with Coomassie Brilliant Blue.inhibited those effects of HSC70. Moreover, we believe
that histatin 3 may affect conformation of HSC70 upon
binding, presumably inhibiting HSC70 function.
In experiments related to TLR stimulation, stimulating
reagents might be contaminated with endotoxin. Our
studies showed that boiling (95°C, 20 min) abrogated the
effects of HSC70 induction, but not of LPS induction
(Figure 1A). Moreover, polymyxin B, an LPS antagonist,
abrogated the effects of LPS induction, but not of
HSC70 induction (data not shown). In addition, endo-
toxin activity in the HSC70 reagents was analyzed by the
limulus amebocyte lysate (LAL) assay and was found to
be low. A recent study has revealed that TLR4 activation
is induced by the HSP70 reagents which may include a
small amount of endotoxin. The results of the study sug-
gest that the stimulatory effect depends on HSP70, even
in the presence of a small amount of endotoxin, and the
structural integrity of HSP70 is essential [42]. Our re-
sults showed that histatin 3 significantly inhibits HSC70-
stimulated NF-κB activation and inflammatory cytokine
production, despite a slight contamination of HSC70
reagents with endotoxins (Figures 2A and 6). Conse-
quently, we can conclude that HSC70 provably affects
NF-κB activation and inflammatory cytokine production
and histatin 3 may inhibit those effects upon its binding
to HSC70. It is also possible that reagents used in stimu-
lating experiments were contaminated with lipoproteins.
We observed a decrease in the levels of NF-κB activation
after stimulation with heated HSC70 (Figure 1C). Fur-
thermore, the levels of inflammatory cytokine produc-
tion after treatment with heated HSC70 were very low
(Figure 4). In addition, histatin 3 significantly inhibited
NF-κB activation and inflammatory cytokine production
caused by HSC70 stimulation (Figures 2B and 6),
although HSPs possess an affinity for lipids [43,44]. It is
also difficult to precisely quantify the small amount of
HSC70 associated with lipids in the HSC70 reagents.
Consequently, if the HSC70 reagents contain HSC70 as-
sociated with lipids (even to a very small extent), our re-
sults might reflect the function of HSC70 in various
physiological forms (for example, HSC70 that exists
under the various physiological conditions of the oral
cavity), because HSC70 derived from the cells might
form lipoproteins [42,43]. We can conclude that histatin
3 binding to HSC70 may inhibit HSC70 activity.
A previous study has reported that HSC70 is released
from injured cells [45]. The release of HSC70 from glial
and K562 erythroleukemic cells has been also observed
[46,47]. Our findings show that extracellular HSC70
stimulates TLR2 and TLR4 and increases the production
of inflammatory cytokines in HGFs (Figure 4). There-
fore, we suggest that HSC70 as well as other HSPs (e.g.,
HSP70 and HSP60) may function as a DAMP for TLRs
and elicit inflammatory responses. The release of HSC70
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postischemic myocardial inflammatory response and to
cardiac dysfunction [48]. Inflammatory response in the
oral cavity is also observed in oral diseases and injuries.
It is tempting to speculate that HSC70 released from the
damaged cells may stimulate oral cells such as HGFs.
Our present findings suggest that inflammatory cytokine
production stimulated by the released HSC70 might be
inhibited by histatin 3 in saliva in HGFs, histatin 3 may
be involved in inflammatory processes in the oral cavity.
Our previous study demonstrated the HSC70-binding
ability of histatins [7]. The study showed that histatin 3
bound to the substrate-binding domain of HSC70 more
strongly than histatin 5 and that histatin 4 did not
bind to HSC70. Our present findings indicate that
the inhibitory effects of histatin 5 on HSC70-stimulated
NF-κB-dependent activation and inflammatory cytokine
production significantly reduced compared with those of
histatin 3 (Figures 2C, 2D, 6C, and 6D). Consequently, the
strength of the association between various histatins and
HSC70 may be related to the function of the complex.
In addition, it seems very likely that the primary struc-
ture of HSC70 is necessary for the function of HSC70 in
TLR-mediated processes. Our findings showed that full-
length HSC70 and not the HSC70 ATPase fragment, can
stimulate TLRs (Figures 1 and 4). In fact, a previous study
reported that the substrate-binding domain of HSC70 is
required to induce the myocardial inflammatory response
[48]. In addition, conformation of HSC70 is also important
for its correct functioning. Our findings show that a rela-
tively protease-resistant conformation is formed upon his-
tatin 3 binding to HSC70, but not in the presence of the
control peptide, P3a (Figure 8), or DSG (data not shown).
These results imply the possibility that there are some ef-
fects on conformation of HSC70. In fact, previous studies
have reported that the peptide-binding domain of HSC70,
as well as the ATPase domain of DnaK (the E. coli homo-
log of HSC70) is capable of undergoing conformational
changes [49-51]. Thus, both the primary structure and
other conformations of HSC70 may contribute to the acti-
vation of TLR signaling.
The innate host defense system recognizes foreign sub-
stances and tries to decrease their effects. One of the vari-
ous host defense factors, pulmonary surfactant protein A
downregulates the activation of TLR2 signaling by PGN
[52]. An inhibitory peptide of TLR signaling, P13, inhibits
both in vitro and in vivo LPS-induced inflammatory re-
sponses [53]. However, the precise mechanisms of this ac-
tion have not been clarified. Histatin 3 is a peptide that
binds directly to HSC70 and inhibits HSC70-induced
TLR2 and TLR4 cell signaling (Figures 2, 6, and 7). There-
fore, the results presented here provided the first evidence
that histatin 3 is a salivary bioactive molecule. This mol-
ecule may prevent early-stage TLR signaling activation byinteracting with TLR stimulators (ligands), such as
HSC70, a putative ligand found in the oral cells.
Conclusion
In this study, we demonstrated the production of inflam-
matory cytokines in oral cells constitutively expressing
HSP and the inhibition of this production by a salivary
protein. Thus, this salivary protein has anti-inflammatory
activity as well as already reported antimicrobial activity. It
is possible that this salivary protein may resolve the HSP-
mediated inflammatory response in the oral cavity. The
present findings further our understanding of the func-
tions and mechanisms of actions of salivary proteins.
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